About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Spot gold broke through $4,360 per ounce, up 0.51% on the day.

2025-12-19

Spot gold broke through $4,360 per ounce, up 0.51% on the day.

Other News
2025-12-19

Individual Stock News: 1. Zhihui Mining (02546.HK) closed up 126% in grey market trading. 2. Haitian Flavouring (03288.HK): Will distribute a special dividend of HK$3 per 10 shares on February 6, 2026. 3. Wasion Holdings (03393.HK): Subsidiary won

Individual Stock News: 1. Zhihui Mining (02546.HK) closed up 126% in grey market trading. 2. Haitian Flavouring (03288.HK): Will distribute a special dividend of HK$3 per 10 shares on February 6, 2026. 3. Wasion Holdings (03393.HK): Subsidiary won the CPFL project in Brazil, with a contract value exceeding RMB 80 million. 4. CSPC Pharmaceutical Group (01093.HK): Topline analysis data obtained from the Phase III clinical trial of secukinumab injection. 5. WuXi AppTec (02359.HK): Acquired a 3.22% stake in a French biopharmaceutical fund for approximately €30 million. 6. Emperor Capital (00717.HK) announced its annual results: Net profit of approximately HK$147 million, a year-on-year increase of 121.4%. 7. Zhiyuan Holdings (00990.HK): Plans to issue a total of 515 million new shares at a discount of approximately 1.4%, raising net proceeds of approximately HK$355.3 million. 8. Zhenro Properties (06158.HK): The company has two new major final judgment cases involving amounts exceeding HK$150 million, with a total execution target amount of HK$807 million. 9. Xinte Energy (01799.HK): A subsidiary plans to sell its 79.92% stake in Xinjiang Fengzhi New Energy Power Generation Partnership, corresponding to a subscribed amount of RMB1.337 billion. 10. Fosun Pharma (02196.HK): Signed a "Cooperation and Option Agreement" with Clavis Bio, under which Fosun Pharma Industry and Clavis Bio will jointly select targets and advance the preclinical development of compounds targeting the selected targets.
2025-12-19

The Trump administration has proposed new rules that would prohibit hospitals that provide gender-aware medical care to patients from participating in Medicare or Medicaid funding programs.

The Trump administration has proposed new rules that would prohibit hospitals that provide gender-aware medical care to patients from participating in Medicare or Medicaid funding programs.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2025 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.

Web Design by YSD